Red Light Therapy: What Photobiomodulation Actually Does

Red light therapy — formally, photobiomodulation — has a habit of attracting both serious mitochondrial research and complete pseudoscience, sometimes in the same room. The truth is in the middle. Specific wavelengths of red and near-infrared light, at specific doses, do meaningful things to cells. Most consumer panels and most marketing claims are not rigorous about either the dose or the indication.

What actually happens at the cellular level

Red light (typically 630–680 nm) and near-infrared (810–850 nm) penetrate skin and underlying tissue to varying depths. The leading mechanism: photons are absorbed by cytochrome c oxidase, the fourth complex in the mitochondrial electron transport chain. This boosts ATP production, modulates reactive oxygen species, and triggers a cascade of secondary signaling.

This isn't a fringe claim — it's well-characterized in cell and animal models. The translation to clinical effect is where the research becomes more variable and dose-dependent.

Where the evidence is reasonable

• Skin and wound healing. Improved collagen synthesis, faster wound closure, reduced fine lines. The effect is modest but reproducible in well-designed trials.
• Hair growth. Low-level laser therapy at specific parameters has FDA clearance for androgenetic alopecia in both men and women. The effect is real, the magnitude is modest, and it requires consistent use over months.
• Muscle recovery and performance. Several small to moderate trials show reduced delayed-onset muscle soreness and slightly improved recovery markers when used pre- or post-exercise.
• Joint pain and osteoarthritis. Low-level laser therapy has reasonable evidence for symptomatic relief.

Where the evidence is thinner

• Major fat loss. Some marketing suggests RLT panels reduce body fat. The trial data is limited and shows small, often clinically irrelevant changes. Don't buy a panel for this reason.
• Cognitive enhancement and Alzheimer's. Transcranial photobiomodulation is an active research area with promising mechanism but limited robust human trial data. Interesting, not yet conclusive.
• "General wellness." The vaguer the claim, the weaker the evidence.

Dose matters more than presence

The single most under-appreciated point in RLT: the biphasic dose-response. Too little light has no effect. Too much actually suppresses the very pathways it's supposed to activate. The therapeutic window is narrower than most consumer panels make obvious.

Practical implications:

• Quality panels publish their irradiance (mW/cm²) at a specified distance. Cheaper devices often don't.
• Sessions of 5–15 minutes at appropriate distance are typically therapeutic. Sessions of 45 minutes at point-blank range are not better; they may be worse.
• Eye protection is reasonable, particularly with high-irradiance devices.

How we think about it

Red and near-infrared light therapy is a useful adjunct in the right setting — particularly for skin, hair, joint pain, and post-training recovery. It is not a primary longevity intervention. We mention it when relevant, recommend it when the indication and the device match, and skip it when the patient already has 12 supplements and 3 supplements they don't need.

Buy a quality panel if the indications fit your goals. Skip it if you're picking it up because it's everywhere on Instagram. There are better places to put your time.